Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL StudyPhilip J. Johnson, Ann‐Lii Cheng, Shukui Qin et al.|Journal of Clinical Oncology|2013Cited by 775
HepatogastroenterologyLung‐Sheng Lu, Chao‐Long Chen, Fu‐Chih Hung et al.|Hepatogastroenterology|2012Cited by 536
Pre-S Deletion and Complex Mutations of Hepatitis B Virus Related to Advanced Liver Disease in HBeAg-Negative PatientsChien‐Hung Chen, Chi‐Sin Changchien, Chao‐Hung Hung et al.|Gastroenterology|2007Cited by 232
Four‐year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patientsTung‐Hung Su, Jia‐Horng Kao, Lein‐Ray Mo et al.|Liver International|2016Cited by 221
Clinical characteristics and prognostic factors of splenic abscess: A review of 67 cases in a single medical center of TaiwanKuo‐Chin Chang, Tsung‐Hui Hu, Seng-Kee Chuah et al.|World Journal of Gastroenterology|2006Cited by 217